» Articles » PMID: 3020547

Identification and Properties of N-methyl-D-aspartate Receptors in Rat Brain Synaptic Plasma Membranes

Overview
Specialty Science
Date 1986 Oct 1
PMID 3020547
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The excitatory amino acid receptors selectively activated by N-methyl-D-aspartate (N-Me-D-Asp) (also known as NMDA) are a major determinant of central nervous system neuronal excitability. We report here that rat brain synaptic plasma membranes contain a distinct population of L-[3H]glutamate binding sites with pharmacological properties indicative of the N-Me-D-Asp receptor. The N-Me-D-Asp sites are readily distinguished from other L-[3H]glutamate binding and uptake sites by their sharp pH optimum, more rapid association rate, preferential localization in synaptic structures, and lack of dependence on temperature and inorganic ions. As with other receptor systems, ligand binding at the N-Me-D-Asp site is reduced by guanine nucleotides but not by adenosine nucleotides. Binding is insensitive to ketamine and cyclazocine, indicating that sigma opiates inhibit N-Me-D-Asp excitation at a site different from that of the N-Me-D-Asp binding site. The quantitative pharmacological properties of N-Me-D-Asp-sensitive L-[3H]glutamate binding sites determined in a well-defined dendritic field (stratum radiatum of CA1) by quantitative autoradiography closely correlate to those of both the electrophysiologically identified N-Me-D-Asp receptors in the same dendritic field and the N-Me-D-Asp sites studied in membrane preparations. Under conditions that selectively reveal N-Me-D-Asp receptors, these sites are found to exhibit considerable anatomical specificity as evidenced by variations within cortical, striatal, and thalamic regions. Autoradiography also showed that regions in rodent and primate brain that are especially sensitive to anoxic and excitotoxic neuronal damage (e.g., Sommer's sector or CA1) have a high level of N-Me-D-Asp sites. Since N-Me-D-Asp receptors are known to contribute to these causes of neuronal loss, their selective distribution partially accounts for the pattern of selective damage seen in these pathological conditions.

Citing Articles

Preoptic and hypothalamic regulation of multi-tiered, chronologically arranged female rat sexual behavior.

Sakuma Y J Physiol Sci. 2023; 73(1):35.

PMID: 38066413 PMC: 10717147. DOI: 10.1186/s12576-023-00890-4.


Activation of NMDA receptors in brain endothelial cells increases transcellular permeability.

Kim K, Jeon M, Kim E, Lee C, Kim D Fluids Barriers CNS. 2022; 19(1):70.

PMID: 36068542 PMC: 9450318. DOI: 10.1186/s12987-022-00364-6.


Memory Disorders Related to Hippocampal Function: The Interest of 5-HTRs Targeting.

Roux C, Leger M, Freret T Int J Mol Sci. 2021; 22(21).

PMID: 34769511 PMC: 8584667. DOI: 10.3390/ijms222112082.


The 1980s: D-AP5, LTP and a Decade of NMDA Receptor Discoveries.

Lodge D, Watkins J, Bortolotto Z, Jane D, Volianskis A Neurochem Res. 2018; 44(3):516-530.

PMID: 30284673 PMC: 6420420. DOI: 10.1007/s11064-018-2640-6.


Selective expression of ligand-gated ion channels in L5 pyramidal cell axons.

Christie J, Jahr C J Neurosci. 2009; 29(37):11441-50.

PMID: 19759293 PMC: 2814532. DOI: 10.1523/JNEUROSCI.2387-09.2009.


References
1.
Cotman C, Taylor D . Isolation and structural studies on synaptic complexes from rat brain. J Cell Biol. 1972; 55(3):696-711. PMC: 2108817. DOI: 10.1083/jcb.55.3.696. View

2.
Bridges R, Hearn T, Monaghan D, Cotman C . A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain. Brain Res. 1986; 375(1):204-9. DOI: 10.1016/0006-8993(86)90977-7. View

3.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

4.
Berrie C, Birdsall N, BURGEN A, Hulme E . Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Commun. 1979; 87(4):1000-5. DOI: 10.1016/s0006-291x(79)80006-6. View

5.
London E, Coyle J . Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol. 1979; 15(3):492-505. View